Monosialotetrahexosylganglioside (GM1) (GM1)

Monosialotetrahexosylganglioside (GM1) is a major glycosphingolipid abundantly expressed on the outer leaflet of neuronal cell membranes, where it serves as a critical component of lipid rafts [9, 12]. It functions as a potent neuroprotective agent by acting as a co-receptor for neurotrophic factors such as Nerve Growth Factor (NGF) and Brain-Derived Neurotrophic Factor (BDNF), modulating their signaling to promote neuronal survival, differentiation, and synaptic plasticity [12, 16]. GM1 also plays a significant role in maintaining calcium homeostasis and facilitating autophagy to prevent the accumulation of toxic protein aggregates [4, 10]. In neurodegenerative diseases like Parkinson's and Huntington's, brain GM1 levels are often markedly reduced, which contributes to neuronal vulnerability and the aggregation of alpha-synuclein [4, 6, 16]. Conversely, a deficiency in the enzyme beta-galactosidase leads to GM1 gangliosidosis, a lysosomal storage disorder characterized by the toxic accumulation of GM1 in the central nervous system [1, 8]. Beyond its physiological roles, GM1 is the specific cell-surface receptor for the B-subunit of Cholera toxin and a primary target of autoantibodies in Guillain-Barré syndrome [9, 14, 16]. Therapeutic strategies targeting GM1 include the administration of exogenous GM1 (e.g., Sygen) for neuroprotection, the use of substrate reduction therapies (e.g., Miglustat) to inhibit its synthesis in storage disorders, and gene therapies (e.g., PBGM01) to restore its degradation [1, 3, 4, 7].

Other names

GM1 gangliosideII3Neu5Ac-Gg4CerGM1aGalactosyl-N-acetylgalactosaminyl-galactosyl-glucosylceramideMonosialotetrahexosylganglioside sodium

GM1 functions as a co-receptor that facilitates the dimerization and phosphorylation of Trk receptors in response to neurotrophic factors [12, 13]. It also interacts with alpha-synuclein to maintain it in a non-toxic, non-aggregating alpha-helical conformation [4]. In infectious contexts, the pentasaccharide head group of GM1 serves as the high-affinity binding site for the B-subunit of Cholera toxin, triggering the endocytosis of the toxic A-subunit into the host cell [9, 14].